Laurent Audoly, managing partner of the pharmaceutical company's new open innovation scheme, spoke to Global Corporate Venturing about its collaboration and investment strategy.
France-based pharmaceutical group Pierre Fabre’s recently launched open innovation initiative, Pierre Fabre Fund for Innovation, will focus on collaboration with biotech companies in the early clinical testing stage, Laurent Audoly, the company’s pharmaceuticals R&D director, told Global Corporate Venturing.
The fund will look to provide financial and strategic support to biotech companies that are in the early stages of clinical development, or within two years of reaching that point. Audoly, who is managing partner of the program, joined Pierre Fabre…
